David R. Spigel
Impact in
- Oncology top 0.05%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 486
- Lung Cancer Research Studies 164
- Cancer Immunotherapy and Biomarkers 138
- Colorectal Cancer Treatments and Studies 97
-
- Lung Cancer Treatments and Mutations 253
- Lung Cancer Diagnosis and Treatment 81
- Co-authors
- John D. HainsworthF. Anthony GrecoHoward A. BurrisScott AntoniaDavid WaterhouseScott GettingerJulie R. BrahmerLecia V. Sequist
- Journals
- Journal of Clinical Oncology (290 papers)Annals of Oncology (67 papers)Journal of Thoracic Oncology (56 papers)Cancer Research (20 papers)Clinical Lung Cancer (15 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
David R. Spigel
592 papers receiving 19.6k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 14.4k
- Pulmonary and Respiratory Medicine 9.9k
- Cancer Research 2.9k
- Hepatology 1.0k
- Pathology and Forensic Medicine 2.3k
Countries citing papers authored by David R. Spigel
This map shows the geographic impact of David R. Spigel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Spigel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Spigel more than expected).
Fields of papers citing papers by David R. Spigel
This network shows the impact of papers produced by David R. Spigel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Spigel. The network helps show where David R. Spigel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David R. Spigel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 21 | |
| 9 | 2023 | 41 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 56 | |
| 12 | Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study Hit paper breakdown → | 2019 | 383 |
| 13 | Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study Hit paper breakdown → | 2018 | 357 |
| 14 | 2017 | 232 | |
| 15 | Results from the phase iii randomized trial of onartuzumab plus erlotinib versus erlotinib in previously treated stage iiib or iv non–small-cell lung cancer: METLung | 2017 | 1 |
| 16 | Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer Hit paper breakdown → | 2016 | 397 |
| 17 | 2014 | 120 | |
| 18 | 2010 | 135 | |
| 19 | 進行性NSCLC患者におけるカルボプラチンとパクリタキセルを併用した,TRAIL-R1アゴニスト単クローン抗体マパツムマブの無作為化第2相試験 | 2010 | 1 |
| 20 | 2009 | 78 |
About David R. Spigel
David R. Spigel is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Oral Surgery, having authored 611 papers that have together received 20.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (253 papers), Lung Cancer Research Studies (164 papers), Cancer Immunotherapy and Biomarkers (138 papers), Cancer Genomics and Diagnostics (97 papers), Colorectal Cancer Treatments and Studies (97 papers), Lung Cancer Diagnosis and Treatment (81 papers), Cancer therapeutics and mechanisms (56 papers) and Neuroendocrine Tumor Research Advances (55 papers). The work is most often cited by research in Oncology (14.4k citations), Pulmonary and Respiratory Medicine (9.9k citations), Cancer Research (2.9k citations), Hepatology (1.0k citations) and Pathology and Forensic Medicine (2.3k citations). David R. Spigel has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include John D. Hainsworth, F. Anthony Greco, Howard A. Burris, Scott Antonia, David Waterhouse, Scott Gettinger, Julie R. Brahmer, Lecia V. Sequist, Mark A. Socinski and Tony Mok. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Cancer Research and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.